U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.36%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.32%)
     
  • USD/JPY

    104.6900
    -0.1500 (-0.14%)
     
  • BTC-USD

    12,917.69
    +12.70 (+0.10%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Beigene (BGNE) CEO John Oyler Sold $15.2 million of Shares

GuruFocus.com
·2 mins read

- By insider

CEO of Beigene (30-Year Financial, Insider Trades) John Oyler (insider trades) sold 54,303 shares of BGNE on 09/29/2020 at an average price of $280.39 a share. The total sale was $15.2 million.


BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent. BeiGene Ltd has a market cap of $25.31 billion; its shares were traded at around $286.44 with and P/S ratio of 86.29. GuruFocus has detected 5 severe warning signs with BeiGene Ltd. .

CEO Recent Trades:

  • CEO John Oyler sold 54,303 shares of BGNE stock on 09/29/2020 at the average price of $280.39. The price of the stock has increased by 2.16% since.

  • CEO John Oyler sold 81,228 shares of BGNE stock on 09/16/2020 at the average price of $253.46. The price of the stock has increased by 13.01% since.

  • CEO John Oyler sold 61,042 shares of BGNE stock on 09/02/2020 at the average price of $233.21. The price of the stock has increased by 22.82% since.

CFO Recent Trades:

  • CFO & Chief Strategy Officer Howard Liang sold 14,000 shares of BGNE stock on 09/14/2020 at the average price of $250.27. The price of the stock has increased by 14.45% since.

Directors and Officers Recent Trades:

  • Chair, Scientific Advisory Brd Xiaodong Wang sold 5,000 shares of BGNE stock on 09/25/2020 at the average price of $280.42. The price of the stock has increased by 2.15% since.

  • President & GM China Xiaobin Wu sold 4,000 shares of BGNE stock on 09/25/2020 at the average price of $280.35. The price of the stock has increased by 2.17% since.

  • Chair, Scientific Advisory Brd Xiaodong Wang sold 5,000 shares of BGNE stock on 09/17/2020 at the average price of $260.27. The price of the stock has increased by 10.05% since.

  • President & GM China Xiaobin Wu sold 4,000 shares of BGNE stock on 09/17/2020 at the average price of $260.33. The price of the stock has increased by 10.03% since.

  • CMO, Hematology Jane Huang sold 3,128 shares of BGNE stock on 09/03/2020 at the average price of $233.07. The price of the stock has increased by 22.9% since.

For the complete insider trading history of BGNE, click here

.This article first appeared on GuruFocus.